Mengzhu Lv

567 total citations
23 papers, 364 citations indexed

About

Mengzhu Lv is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Mengzhu Lv has authored 23 papers receiving a total of 364 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Cancer Research and 6 papers in Surgery. Recurrent topics in Mengzhu Lv's work include Mesenchymal stem cell research (4 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Cancer Mechanisms and Therapy (2 papers). Mengzhu Lv is often cited by papers focused on Mesenchymal stem cell research (4 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Cancer Mechanisms and Therapy (2 papers). Mengzhu Lv collaborates with scholars based in China, Ethiopia and Saint Kitts and Nevis. Mengzhu Lv's co-authors include Shu Guo, Qimin Zhan, Weimin Zhang, Simeng Zhang, Liu Cao, Yuqing Dong, Shude Yang, Wei Zhao, Zhiqian Zhang and Bo Jiang and has published in prestigious journals such as Oncogene, The FASEB Journal and British Journal of Cancer.

In The Last Decade

Mengzhu Lv

20 papers receiving 362 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mengzhu Lv China 11 161 104 74 71 47 23 364
Wenju Wang China 12 131 0.8× 59 0.6× 67 0.9× 70 1.0× 28 0.6× 28 342
Ann Tomanek‐Chalkley United States 12 188 1.2× 56 0.5× 125 1.7× 51 0.7× 51 1.1× 22 462
Bede van Schaijik New Zealand 12 262 1.6× 119 1.1× 165 2.2× 68 1.0× 68 1.4× 25 469
Merdan Serin Türkiye 9 224 1.4× 72 0.7× 190 2.6× 120 1.7× 34 0.7× 35 449
Rosalia de Necochea-Campion United States 14 240 1.5× 63 0.6× 90 1.2× 36 0.5× 56 1.2× 22 451
Ryoji Kitamura Japan 10 207 1.3× 114 1.1× 167 2.3× 105 1.5× 69 1.5× 27 482
Young-Joon Ryu South Korea 10 128 0.8× 63 0.6× 102 1.4× 117 1.6× 65 1.4× 29 359
Jung‐Sun Cho South Korea 10 175 1.1× 45 0.4× 65 0.9× 62 0.9× 27 0.6× 21 365
Nickole Russo United States 14 323 2.0× 108 1.0× 171 2.3× 65 0.9× 88 1.9× 16 574
Antonio d’Amati Italy 13 122 0.8× 50 0.5× 99 1.3× 50 0.7× 91 1.9× 63 461

Countries citing papers authored by Mengzhu Lv

Since Specialization
Citations

This map shows the geographic impact of Mengzhu Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengzhu Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengzhu Lv more than expected).

Fields of papers citing papers by Mengzhu Lv

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mengzhu Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengzhu Lv. The network helps show where Mengzhu Lv may publish in the future.

Co-authorship network of co-authors of Mengzhu Lv

This figure shows the co-authorship network connecting the top 25 collaborators of Mengzhu Lv. A scholar is included among the top collaborators of Mengzhu Lv based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mengzhu Lv. Mengzhu Lv is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Yuhao, Jinting Li, Yiren Cao, & Mengzhu Lv. (2025). Rewired glycolysis by DTL accelerates oncometabolite L-lactate generation to promote breast cancer progression. Frontiers in Oncology. 15. 1583752–1583752.
2.
Xu, Liang, Bing Feng, Qingnan Wu, et al.. (2025). Mutual regulation between cell cycle and transcription termination factor TTF2. Science China Life Sciences. 68(8). 2348–2362.
3.
Lv, Mengzhu, et al.. (2024). Using different zebrafish models to explore liver regeneration. Frontiers in Cell and Developmental Biology. 12. 1485773–1485773.
4.
Liu, Xingyang, Xinxin Cheng, Weimin Zhang, et al.. (2024). Quiescent cancer cells induced by high-density cultivation reveals cholesterol-mediated survival and lung metastatic traits. British Journal of Cancer. 131(10). 1591–1604. 2 indexed citations
5.
Li, Jia, Yan Wang, Qingnan Wu, et al.. (2024). Nlp-dependent ER-to-Golgi transport. International Journal of Biological Sciences. 20(8). 2881–2903. 2 indexed citations
6.
Lv, Mengzhu, et al.. (2023). Dysregulation of cholesterol metabolism in cancer progression. Oncogene. 42(45). 3289–3302. 45 indexed citations
7.
Lv, Mengzhu, Ying Gong, Yan Wang, et al.. (2023). CDK7-YAP-LDHD axis promotes D-lactate elimination and ferroptosis defense to support cancer stem cell-like properties. Signal Transduction and Targeted Therapy. 8(1). 302–302. 50 indexed citations
8.
Cai, Pengcheng, Rui Ni, Mengzhu Lv, et al.. (2023). VEGF signaling governs the initiation of biliary-mediated liver regeneration through the PI3K-mTORC1 axis. Cell Reports. 42(9). 113028–113028. 15 indexed citations
9.
Sun, Wenyang, Jiacheng Lv, Shu Guo, & Mengzhu Lv. (2023). Cellular microenvironment: a key for tuning mesenchymal stem cell senescence. Frontiers in Cell and Developmental Biology. 11. 1323678–1323678. 8 indexed citations
10.
Zhang, Simeng, Xing Wan, Mengzhu Lv, et al.. (2022). TMEM92 acts as an immune-resistance and prognostic marker in pancreatic cancer from the perspective of predictive, preventive, and personalized medicine. The EPMA Journal. 13(3). 519–534. 4 indexed citations
11.
Lv, Jiacheng, et al.. (2022). Protective roles of mesenchymal stem cells on skin photoaging: A narrative review. Tissue and Cell. 76. 101746–101746. 22 indexed citations
12.
Zhou, You Lang, Siyu Liu, Wei Wang, et al.. (2021). The miR-204-5p/FOXC1/GDF7 axis regulates the osteogenic differentiation of human adipose-derived stem cells via the AKT and p38 signalling pathways. Stem Cell Research & Therapy. 12(1). 64–64. 31 indexed citations
13.
Zhang, Simeng, Mengzhu Lv, Yu Cheng, et al.. (2021). Immune landscape of advanced gastric cancer tumor microenvironment identifies immunotherapeutic relevant gene signature. BMC Cancer. 21(1). 1324–1324. 11 indexed citations
14.
Lv, Mengzhu, Simeng Zhang, Yuqing Dong, Liu Cao, & Shu Guo. (2021). PolG Inhibits Gastric Cancer Glycolysis and Viability by Suppressing PKM2 Phosphorylation. Cancer Management and Research. Volume 13. 1559–1570. 12 indexed citations
15.
Tong, Shuang, Chenchao Wang, Qiang Sun, et al.. (2020). BRAFi induced demethylation of miR-152-5p regulates phenotype switching by targeting TXNIP in cutaneous melanoma. APOPTOSIS. 25(3-4). 179–191. 6 indexed citations
16.
Guo, Shu, et al.. (2019). Surgical Treatment Strategy for Severe Rhinophyma With Bilateral Pedicled Nasolabial Flaps. Journal of Craniofacial Surgery. 30(6). e542–e544. 1 indexed citations
17.
Zhang, Yuan, Wei Zhao, Sheng Li, et al.. (2019). CXCL11 promotes self-renewal and tumorigenicity of α2δ1+ liver tumor-initiating cells through CXCR3/ERK1/2 signaling. Cancer Letters. 449. 163–171. 45 indexed citations
18.
Guo, Shu, et al.. (2019). Anthropometric labial analysis of Han Chinese young adults. Skin Research and Technology. 25(4). 499–503. 5 indexed citations
19.
Wang, Yuxin, et al.. (2018). High temperature requirement factor A1 (HTRA1) regulates the activation of latent TGF-β1 in keloid fibroblasts. Cellular and Molecular Biology. 64(1). 107–110. 10 indexed citations
20.
Guo, Shu, et al.. (2013). Anthropometric nasal analysis of Han Chinese young adults. Journal of Cranio-Maxillofacial Surgery. 42(2). 153–158. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026